HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Broadway Stores

This article was originally published in The Rose Sheet

Executive Summary

Broadway Stores: Agrees to merger offer from Federated Department Stores on Aug. 14. The deal is expected to close by the end of October. Under the agreement, shareholders of the 46.9 mil. outstanding Broadway shares will receive .27 shares of Federated stock for each share of Broadway. Federated said it plans to retain and operate "a significant number" of the Broadway stores "divesting the remainder over the next year or so." Most of the retained Broadway stores will be converted into Macy's/Bullock's or Bloomingdale's beginning in 1996. Federated pointed out that the merger paves the way for Bloomingdale's entry into California. Federated says it expects to spend about $525 mil. in converting and remodeling the stores between 1996 and 1999. Broadway shareholders will vote on the merger in October. Zell/Chilmark L.P., which owns a 54% stake in Broadway, supports the merger...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001919

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel